HI
KRBP

Harbour Investments’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Harbour Investments’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 3926
2021
Q3 		$0 Hold
1
– – ﹤0.01% 4096
2021
Q2 		$0 Hold
1
– – ﹤0.01% 4049
2021
Q1 		$0 Buy
+1
New +$293 ﹤0.01% 3781

Other funds holding KRBP

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harbour Investments's KRBP Position: Q4 2021 in Review

Harbour Investments sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q4 2021, closing a stake of 1 share.

Harbour Investments first reported a position in KRBP in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 20 funds tracked by Wall St. Rank hold KRBP as of Q4 2021.

  • Harbour Investments reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 1 Kiromic BioPharma, Inc. Common Stock share in Q4 2021.
  • Harbour Investments first reported a position in Kiromic BioPharma, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Kiromic BioPharma, Inc. Common Stock position peaked at $0 in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.